text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 52-49-3 | Product Number: T3303

Trihexyphenidyl Hydrochloride


Purity: >98.0%(T)(HPLC)
Synonyms:
  • 1-Cyclohexyl-1-phenyl-3-(1-piperidyl)-1-propanol Hydrochloride
  • α-Cyclohexyl-α-phenyl-1-piperidinepropanol Hydrochloride
  • Benzhexol Hydrochloride
Documents:
5G
€83.00
1   9  
25G
€248.00
Contact Us 19  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number T3303
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__2__0H__3__1NO·HCl = 337.93  
Physical State (20 deg.C) Solid
CAS RN 52-49-3
Related CAS RN 144-11-6
Reaxys Registry Number 5667971
PubChem Substance ID 253661351
Merck Index (14) 9695
MDL Number

MFCD00058212

Specifications
Properties (reference)
Melting Point 247 °C(dec.)
Solubility in water Slightly soluble
Degree of solubility in water 10 g/l   25 °C
Solubility (soluble in) Chloroform,Alcohol
Solubility (very slightly) Ether,Benzene
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws: / Compliance with laws, Regulations
RTECS# TN2625000
Transport Information:
HS Number 2933399990
Application
Trihexyphenidyl Hydrochloride: A M1 Muscarinic Cholinergic Receptor Antagonist

Trihexyphenidyl hydrochloride is a M1 muscarinic cholinergic receptor antagonist, and is used for the treatment of parkinsonian syndrome. The exact mechanism of action in parkinsonian syndromes is not precisely understood, but it is known that trihexyphenidyl has a direct anti-spasmodic effect on smooth muscles and a control effect on extrapyramidal disorders which may be caused by certain drugs acting on the central nervous system. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents
Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents